Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Virus|
|Published species reactivity||Mouse|
|Host / Isotype||Mouse / IgG1|
|Immunogen||Purified HBsAg from human plasma.|
|Storage buffer||PBS, pH 7.4|
|Contains||15mM sodium azide|
|Storage Conditions||4° C, do not freeze|
|Tested Applications||Dilution *|
|ELISA (ELISA)||Assay Dependent|
|Immunocytochemistry (ICC)||Assay Dependent|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
|ELISA (ELISA)||See 1 publications below|
This antibody recognizes the following Hepatitis B virus (HBV) subtypes: ayw2, ayw3, ayw4, ayr, adw2, adw4, adrq+, adrq-. Specificity of the antibody HB3 was verified by ELISA on panel of virus subtypes. The antibody HB3 does not cross-block with the antibody HB5 (MA1-19264).
HBsAg (Hepatitis B surface antigen) is a marker of infectivity. Its presence indicates either acute or chronic HBV infection.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Combination of MIDGE-Th1 DNA vaccines with the cationic lipid SAINT-18: studies on formulation, biodistribution and vector clearance.
MA1-19263 was used in ELISA to optimize and characterize the performance of MIDGE-TH1 DNA vaccines complexed with the SAINT-18 cationic lipid
|Endmann A,Oswald D,Riede O,Talman EG,Vos RE,Schroff M,Kleuss C,Ruiters MH,Juhls C||Vaccine (32:3460)||2014|